1 reports of this reaction
11.1% of all LYTTA VESICATORIA reports
#6 most reported adverse reaction
MALAISE is the #6 most commonly reported adverse reaction for LYTTA VESICATORIA, manufactured by SEVENE USA. There are 1 FDA adverse event reports linking LYTTA VESICATORIA to MALAISE. This represents approximately 11.1% of all 9 adverse event reports for this drug.
Patients taking LYTTA VESICATORIA who experience malaise should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
MALAISE is a frequently reported adverse event for LYTTA VESICATORIA, accounting for a significant proportion of all reports.
In addition to malaise, the following adverse reactions have been reported for LYTTA VESICATORIA:
The following drugs have also been linked to malaise in FDA adverse event reports:
MALAISE has been reported as an adverse event in 1 FDA reports for LYTTA VESICATORIA. This does not prove causation, but indicates an association observed in post-market surveillance data.
MALAISE accounts for approximately 11.1% of all adverse event reports for LYTTA VESICATORIA, making it a notable side effect.
If you experience malaise while taking LYTTA VESICATORIA, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.